| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| FOSTER JAMES C | Chairman, President and CEO, Director | C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON | /s/ James C. Foster | 02 Jun 2025 | 0001141722 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRL | Common Stock | Award | $2,340,024 | +17,253 | +8.9% | $135.63 | 210,685 | 30 May 2025 | Direct | F1, F2 |
| holding | CRL | Common Stock | 4,048 | 30 May 2025 | 2022 GRAT | ||||||
| holding | CRL | Common Stock | 20,000 | 30 May 2025 | 2024 GRAT | ||||||
| holding | CRL | Common Stock | 20,000 | 30 May 2025 | 2025 GRAT | ||||||
| holding | CRL | Common Stock | 230 | 30 May 2025 | by Trust | ||||||
| holding | CRL | Common Stock | 750 | 30 May 2025 | By Trust | ||||||
| holding | CRL | Common Stock | 2,250 | 30 May 2025 | By Trust | ||||||
| holding | CRL | Common Stock | 10,000 | 30 May 2025 | Held By Spouse |
| Id | Content |
|---|---|
| F1 | Unvested restricted stock units vest annually on: May 30, 2026; May 30, 2027; May 30, 2028; May 30, 2029. |
| F2 | Reflects the exempt transfer pursuant to Rule 16a-13 of 9,793 shares from the reporting person's indirect holdings to the reporting person's direct holdings. |